Vivesto AB
(OTC: OASMY)
|
1:56 PM UTC, 05/08/24 | |||
---|---|---|---|---|
Last: $0.05 | Change: +0.03 | %Change: +149.50% | Volume: 1,700 |
Open: | $ 0.05 | Volume: | 1,700 | |
---|---|---|---|---|
High: | $ 0.05 | Yield(%) | 0.00 | |
Low: | $ 0.05 | P/E Ratio (ttm): | n/a | |
Dividend ($): | 0.00 | Market Cap ($): | 8.97M | |
EPS ($) | -0.06 | Shares Out: | 179.35M |
% Price Change (last 4 weeks): | 0.00 |
---|---|
% Price Change (last 13 weeks): | 149.50 |
% Price Change (last 26 weeks): | 149.50 |
% Price Change (last 52 weeks): | -37.10 |
% Price Change (year to date): | 150.00 |
Return on Equity (%): | -47.69 |
---|---|
Return on Assets (%): | -43.27 |
Return on Invested Capital (%): | -48.12 |
Gross Profit Margin (%): | n/a |
---|---|
Net Profit Margin (%): | n/a |
Operating Profit Margin (%): | 0.00 |
|
|
50-day Moving Average: | $n/a |
---|---|
200-day Moving Average: | $n/a |
Avg. Daily Vol. (last 50 days): | n/a |
Avg. Daily Vol. (last 200 days): | n/a |
52-wk high: | $0.05 |
52-wk low: | $0.000 |
Bid: | $n/a |
Ask: | $n/a |
Vivesto AB engages in the research and development of drugs. It formulates pharmaceutical products for ovarian and breast cancer for humans and cancer for animals. The company was founded by Julian Aleksov and Bo Cederstrand in 1999 and is headquartered in Solna, Sweden.
|
Vivesto AB
P. O. Box 3061 Solna AB 169 03 Phone: 46.18.50.54.40 Fax: 46.18.51.08.73 http://www.oasmia.com |
Earnings (1year) ($): | -0.06 |
---|---|
Annual Dividend ($): | 0.00 |
Current P/E Ratio (ttm): | n/a |
Book Value ($): | 0.11 |
Cash Flow ($): | -0.07 |
Price/Earnings (x): | n/a |
---|---|
Price/Sales (x): | n/a |
Price/Book (x): | 0.18 |
Price/Cash Flow (x): | n/a |
Quick Ratio (x): | 3.51 |
---|---|
Current Ratio (x): | 3.51 |
LT Debt/Equity (x): | 0.00 |
Total Debt/Equity (x): | 0.00 |